Designed for high performance
Featured Products Promotional FeaturesPosted by: Dental Design 26th September 2022
Clinicians offering implant dentistry need products they can rely on to promote predictability, functionality and aesthetics for their patients. That’s why so many dentists around the world trust Straumann®.
Among the broad portfolio is the Straumann® BLX® implant system, which is supported by extensive clinical research. Making it ideal for immediacy – as well conventional techniques – the BLX® is manufactured from Roxolid® to promote vascularisation, preserve natural structures and provide a solution for compromised cases. [i] [ii] ii [iii] This is further strengthened by the SLActive® surface material, which promotes bone regeneration and predictability for confidence with immediate implant techniques.[iv] [v] [vi] [vii] [viii]
The outcome is an implant system designed for exceptional treatment outcomes in even the most complex of clinical scenarios. To utilise high-performance solutions and elevate your standards of care, discover the Straumann® BLX® implant today.
For more information about the Straumann® BLX implant system, visit www.straumann.com
[i] Ioannidis A, Gallucci GO, Jung RE, Borzangy S, Hämmerle CH, Benic GI. Titanium-zirconium narrow-diameter versus titanium regular diameter implants for anterior and premolar single crowns: 3-year results of a randomized controlled clinical study. J Clin Periodontol. 2015 Nov;42(11):1060-70. doi: 10.1111/jcpe.12468. Epub 2015 Nov 14.
[ii] Al-Nawas B, Domagala P, Fragola G, Freiberger P, Ortiz- Vigón A, Rousseau P, Tondela J. A Prospective Noninterventional Study to Evaluate Survival and Success of Reduced Diameter Implants Made From Titanium-Zirconium Alloy. J Oral Implantol. 2015 Aug;41(4):e118-25. doi: 10.1563/AAID-JOI-D-13-00149. Epub 2014 Mar 25.
[iii] Altuna P, Lucas-Taulé E, Gargallo-Albiol J, Figueras-Álvarez O, Hernández-Alfaro F, Nart J. Clinical evidence on titanium-zirconium dental implants: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2016 Jul;45(7):842-50. doi: 10.1016/j.ijom.2016.01.004. Epub 2016 Feb 3.
[iv] Kuchler U, Chappuis V, Bornstein mm, Siewczyk M, Gruber R, Maestre L, Buser D. Development of Implant Stability Quotient values of implants placed with simultaneous sinus floor elevation – results of a prospective study with 109 implants. Clin. Oral Impl. Res. 28, 2017, 109– 115.
[v] Schwarz, F., et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA® titanium implants: a pilot study in dogs. J Clin.Periodontol. 34.1 (2007): 78–86.
[vi] Schwarz, F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA titanium implants: an immunohistochemical study in dogs. J Clin.Periodontol. 35.1 (2008): 64–75.
[vii] El Chaar E, Zhang L, Zhou Y, et al. (Superior) osseointegration of super hydrophilic implants placed in defect grafted bones. Int J Oral Maxillofac Implants 2018. (article in press).
[viii] Nicolau P, Guerra F, Reis R, Krafft T, Benz K , Jackowski J. 10-year outcomes with immediate and early-loaded implants with a chemically modified SLA surface, Quintessence Int. (article in press).
